6th November 2026, Friday

Latest Posts

HealthTech News

  • Drug discovery by scientists joins world’s largest trial of Parkinson’s treatments
    on November 6, 2026 at 4:00 pm

    A liver drug could be used to slow down the progression of Parkinson’s disease as it joins the world’s largest trial of treatments for the condition.

  • AI-powered smartwatch detects high blood pressure with sensitivity similar to office screening
    on November 6, 2026 at 4:00 pm

    Smartwatches may be able to detect hypertension (high blood pressure) with the help of an artificial intelligence (AI) system that interprets sensor readings, a paper in Nature reports. Tests of the system, trialed using a consumer smartwatch, show that it can detect hypertension at similar sensitivities to traditional office-based blood pressure screening methods.

  • New research identifies promising strategy to support eating disorder recovery for adults with autism
    on November 6, 2026 at 3:40 pm

    In the first study of its kind, researchers from the University of Aberdeen and the University of Edinburgh worked with adults with autism who had received treatment for eating disorders. Participants viewed personalized, autism-affirming peer support, where people with shared lived experience support one another, as potentially valuable for recovery. The research is published in the journal Eating Disorders.

  • Genetic variant may increase the risk of pneumonia
    on November 6, 2026 at 3:40 pm

    Pneumonia is a common and sometimes serious infection that affects 20,000–30,000 people in Sweden every year. Well-known risk factors include advanced age, smoking and underlying medical conditions. In a new study published in eBioMedicine, researchers at Lund University and Skåne University Hospital have shown that genetic differences in the innate immune system can also influence the risk of developing the disease.

  • Metformin may lower risk of long COVID or death by 53% when prescribed early
    on November 6, 2026 at 3:20 pm

    Long COVID—or new-onset symptoms or worsening health conditions after SARS-CoV-2 infection—can lower quality of life. Finding a way to prevent it would be a welcome relief for those worried about the long-term effects of the viral infection.